Roth Capital Starts Champions Oncology (CSBR) at Buy
Tweet Send to a Friend
Roth Capital analyst Scott Henry initiates coverage on Champions Oncology (NASDAQ: CSBR) with a Buy rating and a price ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE